keyword
https://read.qxmd.com/read/38710000/radiologic-lag-and-brain-mri-lesion-dynamics-during-attacks-in-mog-antibody-associated-disease
#1
MULTICENTER STUDY
Laura Cacciaguerra, Omar Abdel-Mannan, Dimitrios Champsas, Kshitij Mankad, Karl N Krecke, John J Chen, Stephanie B Syc-Mazurek, Vyanka Redenbaugh, Alfonso S Lopez-Chiriboga, Cristina Valencia-Sanchez, Cheryl Hemingway, Jan-Mendelt Tillema, Olga Ciccarelli, Sean J Pittock, Yael Hacohen, Eoin P Flanagan
BACKGROUND AND OBJECTIVES: Knowledge of the evolution of CNS demyelinating lesions within attacks could assist diagnosis. We evaluated intra-attack lesion dynamics in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) vs multiple sclerosis (MS) and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD). METHODS: This retrospective observational multicenter study included consecutive patients from Mayo Clinic (USA) and Great Ormond Street Hospital for Children (UK)...
May 28, 2024: Neurology
https://read.qxmd.com/read/38709925/cancer-stromal-cell-interactions-in-breast-cancer-brain-metastases-induce-glycocalyx-mediated-resistance-to-her2-targeting-therapies
#2
JOURNAL ARTICLE
Marie-Anne Goyette, Laura E Stevens, Carolyn R DePinho, Marco Seehawer, Jun Nishida, Zheqi Li, Callahan M Wilde, Rong Li, Xintao Qiu, Alanna L Pyke, Stephanie Zhao, Klothilda Lim, Gabrielle S Tender, Jason J Northey, Nicholas M Riley, Henry W Long, Carolyn R Bertozzi, Valerie M Weaver, Kornelia Polyak
Brain metastatic breast cancer is particularly lethal largely due to therapeutic resistance. Almost half of the patients with metastatic HER2-positive breast cancer develop brain metastases, representing a major clinical challenge. We previously described that cancer-associated fibroblasts are an important source of resistance in primary tumors. Here, we report that breast cancer brain metastasis stromal cell interactions in 3D cocultures induce therapeutic resistance to HER2-targeting agents, particularly to the small molecule inhibitor of HER2/EGFR neratinib...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38709242/transfected-sars-cov-2-spike-dna-for-mammalian-cell-expression-inhibits-p53-activation-of-p21-waf1-trail-death-receptor-dr5-and-mdm2-proteins-in-cancer-cells-and-increases-cancer-cell-viability-after-chemotherapy-exposure
#3
JOURNAL ARTICLE
Shengliang Zhang, Wafik S El-Deiry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization of tumor suppressor p53 protein. In-silico analysis previously suggested that SARS-CoV-2 spike interacts with p53 directly but this putative interaction has not been demonstrated in cells. We examined the interaction between SARS-CoV-2 spike, p53 and MDM2 (E3 ligase, which mediates p53 degradation) in cancer cells using an immunoprecipitation assay...
May 3, 2024: Oncotarget
https://read.qxmd.com/read/38709106/human-coronavirus-oc43-nanobody-neutralizes-virus-and-protects-mice-from-infection
#4
JOURNAL ARTICLE
Amy Adair, Li Lynn Tan, Jackson Feng, Jason Girkin, Nathan Bryant, Mingyang Wang, Francesca Mordant, Li-Jin Chan, Nathan W Bartlett, Kanta Subbarao, Phillip Pymm, Wai-Hong Tham
UNLABELLED: Human coronavirus (hCoV) OC43 is endemic to global populations and usually causes asymptomatic or mild upper respiratory tract illness. Here, we demonstrate the neutralization efficacy of isolated nanobodies from alpacas immunized with the S1B and S1C domain of the hCoV-OC43 spike glycoprotein. A total of 40 nanobodies bound to recombinant OC43 protein with affinities ranging from 1 to 149 nM. Two nanobodies WNb 293 and WNb 294 neutralized virus at 0.21 and 1.79 nM, respectively...
May 6, 2024: Journal of Virology
https://read.qxmd.com/read/38709084/glycoproteomic-and-proteomic-analysis-of-burkholderia-cenocepacia-reveals-glycosylation-events-within-flif-and-motb-are-dispensable-for-motility
#5
JOURNAL ARTICLE
Jessica M Lewis, Leila Jebeli, Pauline M L Coulon, Catrina E Lay, Nichollas E Scott
UNLABELLED: Across the Burkholderia genus O -linked protein glycosylation is highly conserved. While the inhibition of glycosylation has been shown to be detrimental for virulence in Burkholderia cepacia complex species, such as Burkholderia cenocepacia , little is known about how specific glycosylation sites impact protein functionality. Within this study, we sought to improve our understanding of the breadth, dynamics, and requirement for glycosylation across the B. cenocepacia O- glycoproteome...
May 6, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38709075/pan-cancer-interrogation-of-b7-h3-cd276-as-an-actionable-therapeutic-target-across-human-malignancies
#6
JOURNAL ARTICLE
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Neeraj Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S Hoon, Jacob J Orme, Oliver Sartor, Ari Vanderwalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
B7-H3 (CD276) is a transmembrane glycoprotein of the B7 immune checkpoint superfamily that has emerged as a promising therapeutic target. To better understand the applicability of B7-H3-directed therapies, we analyzed 156,791 samples comprising 50 cancer types to interrogate the clinical, genomic, transcriptomic, and immunological correlates of B7-H3 mRNA expression. DNA (592-gene/whole-exome) and RNA (whole-transcriptome) sequencing was performed from samples submitted to Caris Life Sciences (Phoenix, AZ)...
May 6, 2024: Cancer Res Commun
https://read.qxmd.com/read/38708316/myelin-oligodendrocyte-glycoprotein-mog-antibody-associated-optic-neuritis-a-case-report-and-literature-review
#7
Barbara Nowacka, Wojciech Lubiński, Beata Kaźmierczak
BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG)-IgG-associated optic neuritis (ON) is a new subset of demyelinating optic neuropathy. CASE REPORT: This study presents a case of a 49-year-old woman with MOG-IgG-positive ON, who reported to the ophthalmic emergency room with decreased visual acuity, retrobulbar pain and red color desaturation in her left eye. Abnormalities in the ophthalmological examination were: decreased Snellen's distance best-corrected visual acuity (DBCVA) to 0...
2024: International Medical Case Reports Journal
https://read.qxmd.com/read/38707900/potential-therapeutic-targets-for-membranous-nephropathy-proteome-wide-mendelian-randomization-and-colocalization-analysis
#8
JOURNAL ARTICLE
Zhihang Su, Qijun Wan
BACKGROUND: The currently available medications for treating membranous nephropathy (MN) still have unsatisfactory efficacy in inhibiting disease recurrence, slowing down its progression, and even halting the development of end-stage renal disease. There is still a need to develop novel drugs targeting MN. METHODS: We utilized summary statistics of MN from the Kiryluk Lab and obtained plasma protein data from Zheng et al. We performed a Bidirectional Mendelian randomization analysis, HEIDI test, mediation analysis, Bayesian colocalization, phenotype scanning, drug bank analysis, and protein-protein interaction network...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38706870/functional-diversification-of-innate-and-inflammatory-immune-responses-mediated-by-antibody-fragment-crystallizable-activities-against-sars-cov-2
#9
JOURNAL ARTICLE
Martina Severa, Marilena Paola Etna, Emanuele Andreano, Daniela Ricci, Giada Cairo, Stefano Fiore, Andrea Canitano, Andrea Cara, Paola Stefanelli, Rino Rappuoli, Anna Teresa Palamara, Eliana Marina Coccia
Monoclonal antibodies (mAb) targeting the SARS-CoV-2 Spike (S) glycoprotein have been exploited for the treatment of severe COVID-19. In this study, we evaluated the immune-regulatory features of two neutralizing anti-S mAbs (nAbs), named J08 and F05, with wild-type (WT) conformation or silenced Fc functions. In the presence of D614G SARS-CoV-2, WT nAbs enhance intracellular viral uptake in immune cells and amplify antiviral type I Interferon and inflammatory cytokine and chemokine production without viral replication, promoting the differentiation of CD16+ inflammatory monocytes and innate/adaptive PD-L1+ and PD-L1+ CD80+ plasmacytoid Dendritic Cells...
May 17, 2024: IScience
https://read.qxmd.com/read/38706402/follow-up-and-comparative-assessment-of-sars-cov-2-iga-igg-neutralizing-and-total-antibody-responses-after-bnt162b2-or-mrna-1273-heterologous-booster-vaccination
#10
COMPARATIVE STUDY
Salma Younes, Eleonora Nicolai, Massimo Pieri, Sergio Bernardini, Hanin I Daas, Duaa W Al-Sadeq, Nadin Younes, Farah M Shurrab, Parveen B Nizamuddin, Fathima Humaira, Nader Al-Dewik, Hadi M Yassine, Laith J Abu-Raddad, Ahmed Ismail, Gheyath K Nasrallah
BACKGROUND: Priming with ChAdOx1 followed by heterologous boosting is considered in several countries. Nevertheless, analyses comparing the immunogenicity of heterologous booster to homologous primary vaccination regimens and natural infection are lacking. In this study, we aimed to conduct a comparative assessment of the immunogenicity between homologous primary vaccination regimens and heterologous prime-boost vaccination using BNT162b2 or mRNA-1273. METHODS: We matched vaccinated naïve (VN) individuals (n = 673) with partial vaccination (n = 64), primary vaccination (n = 590), and primary series plus mRNA vaccine heterologous booster (n = 19) with unvaccinated naturally infected (NI) individuals with a documented primary SARS-CoV-2 infection (n = 206)...
May 2024: Influenza and Other Respiratory Viruses
https://read.qxmd.com/read/38705315/a-comprehensive-review-on-hemocyanin-from-marine-products-structure-functions-its-implications-for-the-food-industry-and-beyond
#11
REVIEW
Ruiyang Ji, Leying Guan, Ziyan Hu, Yishen Cheng, Meng Cai, Guanghua Zhao, Jiachen Zang
Hemocyanin, an oxygen-transport protein, is widely distributed in the hemolymph of marine arthropods and mollusks, playing an important role in their physiological processes. Recently, hemocyanin has been recognized as a multifunctional glycoprotein involved in the immunological responses of aquatic invertebrates. Consequently, the link between hemocyanin functions and their potential applications has garnered increased attention. This review offers an integrated overview of hemocyanin's structure, physicochemical characteristics, and bioactivities to further promote the utilization of hemocyanin derived from marine products...
May 3, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38705015/blood-parameters-in-pediatric-myelin-oligodendrocyte-glycoprotein-antibody-associated-disorders
#12
JOURNAL ARTICLE
Alina Peternell, Christian Lechner, Markus Breu, Martin Preisel, Mareike Schimmel, Astrid Eisenkölbl, Joachim Zobel, Eva-Maria Wendel, Markus Reindl, Kevin Rostásy, Matthias Baumann
BACKGROUND AND OBJECTIVES: Patients with myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) clinically present e.g. with acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), transverse myelitis (TM) or aquaporin-4-IgG (AQP4-IgG) negative neuromyelitis optica spectrum disorders (NMOSD)-like phenotypes. We aimed to analyze and compare blood parameters in children with MOGAD, AQP4-IgG-positive NMOSD (hence NMOSD), multiple sclerosis (MS) and healthy controls (HC)...
April 24, 2024: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/38704938/novel-pyxinol-amide-derivatives-bearing-an-aliphatic-heterocycle-as-p-glycoprotein-modulators-for-overcoming-multidrug-resistance
#13
JOURNAL ARTICLE
Liping Yu, Ruiyin Ren, Shuang Li, Chen Zhang, Cheng Chen, Hanqi Lv, Zongji Zou, Xinjie Pei, Zhihua Song, Peng Zhang, Hongbo Wang, Gangqiang Yang
P-glycoprotein (Pgp) modulators are promising agents for overcoming multidrug resistance (MDR) in cancer chemotherapy. In this study, via structural optimization of our lead compound S54 (nonsubstrate allosteric inhibitor of Pgp), 29 novel pyxinol amide derivatives bearing an aliphatic heterocycle were designed, synthesized, and screened for MDR reversal activity in KBV cells. Unlike S54, these active derivatives were shown to transport substrates of Pgp. The most potent derivative 4c exhibited promising MDR reversal activity (IC50 of paclitaxel = 8...
May 1, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38704747/-not-available
#14
JOURNAL ARTICLE
Beatrice Aiuto, Simona Cirrincione, Maria Gabriella Giuffrida, Laura Cavallarin, Chiara Portesi, Andrea Mario Rossi, Giorgio Borreani, Giovanni Rolla, Massimo Geuna, Stefania Nicola, Anna Quinternetto, Lucrezia Alessi, Elena Saracco, Luisa Brussino, Cristina Lamberti
Alpha-gal syndrome (AGS) is a mammalian meat allergy associated with tick bites and specific IgE to the oligosaccharide galactose-α-1,3-galactose (α-gal). Recent studies have shown that 10-20% of AGS patients also react to the dairy proteins. Considering the already described role of the meat lipid fraction in AGS manifestations, the aim of this work has been to investigate whether the milk fat globule proteins (MFGPs) could be involved in AGS. The MFGPs are extracted and their recognition by the IgE of AGS patients is proved through immunoblotting experiments...
May 5, 2024: Molecular Nutrition & Food Research
https://read.qxmd.com/read/38704585/lipocalin-2-as-a-prognostic-marker-in-patients-with-acute-exacerbation-of-idiopathic-pulmonary-fibrosis
#15
JOURNAL ARTICLE
Hiroki Tanahashi, Hiroshi Iwamoto, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
BACKGROUND: Lipocalin-2 (LCN2) is a secretory glycoprotein upregulated by oxidative stress; moreover, patients with idiopathic pulmonary fibrosis (IPF) have shown increased LCN2 levels in bronchoalveolar lavage fluid (BALF). This study aimed to determine whether circulatory LCN2 could be a systemic biomarker in patients with IPF and to investigate the role of LCN2 in a bleomycin-induced lung injury mouse model. METHODS: We measured serum LCN2 levels in 99 patients with stable IPF, 27 patients with acute exacerbation (AE) of IPF, 51 patients with chronic hypersensitivity pneumonitis, and 67 healthy controls...
May 4, 2024: Respiratory Research
https://read.qxmd.com/read/38704475/immunoinformatics-design-of-a-structural-proteins-driven-multi-epitope-candidate-vaccine-against-different-sars-cov-2-variants-based-on-fynomer
#16
JOURNAL ARTICLE
Javad Sarvmeili, Bahram Baghban Kohnehrouz, Ashraf Gholizadeh, Dariush Shanehbandi, Hamideh Ofoghi
The ideal vaccines for combating diseases that may emerge in the future require more than simply inactivating a few pathogenic strains. This study aims to provide a peptide-based multi-epitope vaccine effective against various severe acute respiratory syndrome coronavirus 2 strains. To design the vaccine, a library of peptides from the spike, nucleocapsid, membrane, and envelope structural proteins of various strains was prepared. Then, the final vaccine structure was optimized using the fully protected epitopes and the fynomer scaffold...
May 4, 2024: Scientific Reports
https://read.qxmd.com/read/38704398/genetic-association-of-inflammatory-marker-glyca-with-lung-function-and-respiratory-diseases
#17
JOURNAL ARTICLE
Yanjun Guo, Quanhong Liu, Zhilin Zheng, Mengxia Qing, Tianci Yao, Bin Wang, Min Zhou, Dongming Wang, Qinmei Ke, Jixuan Ma, Zhilei Shan, Weihong Chen
Association of circulating glycoprotein acetyls (GlycA), a systemic inflammation biomarker, with lung function and respiratory diseases remain to be investigated. We examined the genetic correlation, shared genetics, and potential causality of GlycA (N = 115,078) with lung function and respiratory diseases (N = 497,000). GlycA showed significant genetic correlation with FEV1 (rg  = -0.14), FVC (rg  = -0.18), asthma (rg  = 0.21) and COPD (rg  = 0...
May 4, 2024: Nature Communications
https://read.qxmd.com/read/38704123/towards-harmonized-interpretation-of-anticardiolipin-and-anti-%C3%AE-2-glycoprotein-i-antibody-detection-for-diagnosis-of-antiphospholipid-syndrome-using-defined-level-intervals-and-likelihood-ratios-communication-from-the-isth-ssc-subcommittee-on-lupus-anticoagulant
#18
Arne Vandevelde, Jean-Christophe Gris, Gary W Moore, Jacek Musiał, Stéphane Zuily, Denis Wahl, Katrien M J Devreese
BACKGROUND: Improving harmonization of the clinical interpretation of anticardiolipin (aCL) and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG/IgM in the diagnosis of antiphospholipid syndrome (APS) is desirable. Likelihood ratios (LR) with corresponding test-result intervals can identify the power of a test to discriminate between a diseased and non-diseased patient and may be useful for the semiquantitative interpretation of aCL/aβ2GPI results. OBJECTIVES: To determine moderate and high thresholds for aCL and aβ2GPI IgG/IgM determined with chemiluminescent immunoassay, enzyme-linked immunosorbent assay, fluorescence enzyme immunoassay, and multiplex flow immunoassay...
May 2, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38703776/structural-elucidation-of-the-mesothelin-mucin-16-ca125-interaction
#19
JOURNAL ARTICLE
Peter B Rupert, Matthew Buerger, Della J Friend, Roland K Strong
Mesothelin (MSLN) is a cell-surface glycoprotein expressed at low levels on normal mesothelium but overexpressed in many cancers. Mesothelin has been implicated to play role/s in cell adhesion and multiple signaling pathways. Mucin-16/CA125 is an enormous cell-surface glycoprotein, also normally expressed on mesothelium and implicated in the progression and metastasis of several cancers, and directly binds mesothelin. However, the precise biological function/s of mesothelin and mucin-16/CA125 remain mysterious...
April 24, 2024: Structure
https://read.qxmd.com/read/38703720/a-protective-effect-of-lower-mhc-ii-expression-in-mogad
#20
JOURNAL ARTICLE
Ariel Rechtman, Omri Zveik, Nitsan Haham, Livnat Brill, Adi Vaknin-Dembinsky
Myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) is a demyelinating central nervous system disorder. We aimed to uncover immune pathways altered in MOGAD to predict disease progression. Using nanostring nCounter technology, we analyzed immune gene expression in PBMCs from MOGAD patients and compare it with healthy controls (HCs). We found 35 genes that distinguished MOGAD patients and HCs. We then validated those results in a larger cohort including MS and NMOSD patients. Expressions of HLA-DRA was significantly lower in MOGAD patients...
April 26, 2024: Journal of Neuroimmunology
keyword
keyword
23964
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.